Status:
TERMINATED
Microbiome Alterations in IL10RA-deficient Patients After HSCT
Lead Sponsor:
Children's Hospital of Fudan University
Conditions:
Inflammatory Bowel Diseases
Microbiota
Eligibility:
All Genders
1-6 years
Brief Summary
To elucidate the longitudinal development of intestinal microbiota in patients with IL10RA deficiency after hematopoietic stem cell transplantation (HSCT). The investigators planned to collect fecal s...
Detailed Description
Hematopoietic stem cell transplantation is considered the only curative therapy for patients with interleukin-10 receptor-A(IL10RA) deficiency. The investigators aimed to collect the fecal samples of ...
Eligibility Criteria
Inclusion
- IL10RA gene mutations;
- Eligible for hematopoietic stem cell transplantation.
Exclusion
- Unwilling to participate.
Key Trial Info
Start Date :
October 1 2017
Trial Type :
OBSERVATIONAL
Allocation :
ACTUAL
End Date :
February 28 2020
Estimated Enrollment :
13 Patients enrolled
Trial Details
Trial ID
NCT03752372
Start Date
October 1 2017
End Date
February 28 2020
Last Update
August 12 2020
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
Children's hospital of Fudan university
Shanghai, Shanghai Municipality, China, 201102